000 01351 a2200409 4500
005 20250515152719.0
264 0 _c20090303
008 200903s 0 0 eng d
022 _a1433-6510
040 _aNLM
_beng
_cNLM
100 1 _aShastri, Yogesh M
245 0 0 _aComparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.
_h[electronic resource]
260 _bClinical laboratory
_c2008
300 _a389-90 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFeces
_xchemistry
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdiagnosis
650 0 4 _aLeukocyte L1 Antigen Complex
_xanalysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aPyruvate Kinase
_xanalysis
650 0 4 _aSensitivity and Specificity
650 0 4 _aYoung Adult
700 1 _aPovse, Nada
700 1 _aSchröder, Oliver
700 1 _aStein, Jürgen
773 0 _tClinical laboratory
_gvol. 54
_gno. 9-10
_gp. 389-90
999 _c18548619
_d18548619